logo

ATXS(Delisted)

Astria Therapeutics·NASDAQ
--
--(--)
5.42 / 10
Netural

Capital flows are positive overall (score 7.63/10), with block, small, medium, and extra-large inflows trending upward—except for a slight negative bias in large-cap flows. This indicates institutional accumulation despite the neutral technical backdrop. Analyst coverage is thin (only one active analyst) with a unanimous Neutral rating, and the historical weighted rating is 3.20, reflecting limited conviction. The sentiment score of 5.42 is neutral, aligning with the cautious analyst stance and mixed fund flow signals.

FundamentalSentiment(5.42)Technical
Fund Flow Rating
Analyst RatingStrong Buy

Wall Street Opinions

Strong Buy

Strong Buy

0%

Buy

0%

Hold

0%

Sell

0%

Strong Sell

0%

Date2025-11-12
InstitutionCantor Fitzgerald
Times predicted3
Historical Win Rate66.7%
Is money flowing into or out of ATXS?
  • ATXS holds a Bearish analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 5.42/10 (Netural).